Global Mantle Cell Lymphoma Therapeutics Market Forecast to Reach $3.5 Billion by 2029, Driven by 7.7% CAGR
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Outlook for the Mantle Cell Lymphoma Therapeutics Market Heading Into 2029?
The market for therapeutic treatments of mantle cell lymphoma has seen substantial growth recently. The market, which is projected to increase from $2.42 billion in 2024 to $2.6 billion in 2025, is growing at a compound annual growth rate (CAGR) of 7.1%. The historical growth of this market can be linked to advancements in research, successful clinical trials, enhanced diagnostic tools, expanded access to treatment, and joint research initiatives.
The therapeutics market for mantle cell lymphoma is projected to witness robust expansion in the upcoming years. The market is forecasted to reach $3.5 billion by 2029, growing at a compound annual growth rate (CAGR) of 7.7%. Several factors contributing to this expected growth in the forecast period include advancements in targeted therapies, inventions in immunotherapy, development in personalized medicine, global market expansion, and rising frequency rates. Major trends observed in the forecast period encompass advancements in immunotherapy, evolution of precision medicine and biomarker development, specific pathway targeted therapies, combo therapies, and the incorporation of artificial intelligence (AI).
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10813&type=smp
Which Factors Are Pushing The Mantle Cell Lymphoma Therapeutics Market Forward?
The mantle cell lymphoma therapeutics market is predicted to grow, owing to the increasing incidence of mantle cell lymphoma. Mantle cell lymphoma is a subtype of non-Hodgkin lymphoma, a cancer type that impacts the lymphatic system. Therapies for Mantle Cell Lymphoma aid to decrease its prevalence by offering treatment and management solutions, boosting patient outcomes, prolonging survival, and lessening the disease burden. For example, the National Library of Medicine, a biomedical library run by the U.S. Federal Government, reported in December 2022 that mantle cell lymphoma’s yearly incidence is one per 200,000 people, accounting for 5% of all non-Hodgkin lymphomas. As a result, the increasing incidence of mantle cell lymphoma is fueling the expansion of the mantle cell lymphoma therapeutics market.
Which Segment Held The Largest Share In The Mantle Cell Lymphoma Therapeutics Market In 2025?
The mantle cell lymphoma therapeutics market covered in this report is segmented –
1) By Type: Combination Therapy, Monotherapy
2) By Mechanism of Action: Bruton Tyrosine Kinase Inhibitors, Alkylating Agents, Deoxyribonucleic Acid Synthesis Inhibitors, Microtubule Inhibitors, Monoclonal Antibodies, Other Mechanisms
3) By Route of Administration: Oral, Parenteral
4) By Application: Hospital, Research Institute, Other Applications
Subsegments:
1) By Combination Therapy: Chemotherapy Combinations, Targeted Therapy Combinations, Immunotherapy Combinations
2) By Monotherapy: Single-Agent Chemotherapy, Targeted Therapy Monotherapy, Immunotherapy Monotherapy
How Are Key Trends Driving Expansion In The Mantle Cell Lymphoma Therapeutics Industry?
The rise in the development of tailored therapy medication is a primary trajectory gaining traction in the mantle cell lymphoma therapeutics market. Leading firms in this market are formulating new pharmaceuticals for specific therapy in a bid to maintain their market standing. Notably, in March 2023, the UK’s AstraZeneca plc secured approval from National Medical Products Administration (NMPA) to distribute Calquence (acalabrutinib) in China, targeting adult patients suffering from mantle cell lymphoma (MCL). Calquence (acalabrutinib), a selective inhibitor of Bruton’s tyrosine kinase (BTK), presents a viable and well-tolerable new treatment alternative for the management of mantle cell lymphoma.
Which Organizations Are Driving Progress In The Mantle Cell Lymphoma Therapeutics Industry?
Major companies operating in the mantle cell lymphoma therapeutics market include AstraZeneca plc, Celgene Corporation, Johnson & Johnson Consumer Inc., Takeda Pharmaceutical Company Limited, Bayer Aktiengesellschaft, Eli Lilly and Company, Amgen Inc., GlaxoSmithKline plc, Kite Pharma Inc., Gilead Sciences Inc., AbbVie Inc., Bristol-Myers Squibb Company, Novartis AG, Merck & Co. Inc., Massive Bio Inc., Juno Therapeutics Inc., Nurix Therapeutics Inc., Janssen Biotech Inc., TG Therapeutics Inc., F. Hoffmann-La Roche AG, Astex Pharmaceuticals Inc., Astellas Pharma Inc., BeiGene Ltd., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Exelixis Inc., Hutchison China MediTech Limited, Incyte Corporation, Ionis Pharmaceuticals Inc.
Get The Full Report Here:
Which Region Is Expected To Experience The Highest Growth In The Mantle Cell Lymphoma Therapeutics Industry?
North America was the largest region in the global mantle cell lymphoma therapeutics market in 2024. The regions covered in the mantle cell lymphoma therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=10813&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
